The association between normal capillary refill time and 28-day mortality in septic shock patients subjected to early hemodynamic resuscitation
PURPOSE: Capillary refill time (CRT)-guided resuscitation improves outcomes in septic shock by targeting abnormal CRT. However, whether a normal baseline CRT, resulting in no additional attempts to optimize hemodynamics, is associated with mortality remains unclear. We evaluated the association between normal baseline CRT and 28-day mortality in patients with septic shock undergoing protocolized resuscitation. METHODS: This post-hoc analysis included all randomized patients from the ANDROMEDA-SHOCK 1 and 2 trials. CRT was classified as normal (≤3 s) or abnormal (>3 s). The primary outcome was 28-day mortality, analyzed using Cox proportional hazards regression and reported as hazard ratios (HR) with 95% confidence intervals (CI). Secondary outcomes included ICU and hospital length of stay and 90-day mortality. RESULTS: Among 1885 patients, 691 (36.7%) had normal baseline CRT. Despite normal CRT, many had abnormal hemodynamic features: 335 (48.5%) had heart rate > 100/min, 258 (37.3%) systolic arterial pressure < 100 mmHg, 152 (22.0%) mean arterial pressure < 65 mmHg, 157 (22.7%) diastolic arterial pressure < 50 mmHg, and 683 (98.8%) lactate >2 mmol/L. Patients with normal baseline CRT had significantly lower 28-day mortality than those with abnormal CRT (21.1% vs. 34.3%; HR 0.61, 95% CI 0.50-0.74; p < 0.001) similarly for 90-day mortality (25.9% versus 40.6%; HR 0.61, 95% CI 0.52-0.73; p < 0.001). CONCLUSION: In the ANDROMEDA-SHOCK trials, normal baseline CRT was associated with significantly lower 28- and 90-day mortality, although mortality remained still quite high. Further research should investigate how treatment of septic shock patients with normal CRT can be improved. TRIAL REGISTRATION: The ANDROMEDA-SHOCK 1 trial: ClinicalTrials.gov Identifier: NCT03078712 (study start at: 2017-03-01). The ANDROMEDA-SHOCK 2 trial: ClinicalTrials.gov Identifier: NCT05057611 (study start at: 2022-03-18).
Authors
- Jan Bakker (ORCID: https://orcid.org/0000-0003-2236-7391)
- Corstiaan A. den Uil (ORCID: https://orcid.org/0000-0003-0635-2843)
- Jean–Louis Teboul (ORCID: https://orcid.org/0000-0002-5748-7820)
- Marcela de Almeida Lopes (ORCID: https://orcid.org/0000-0002-9304-7363)
- Glenn Hernández P (ORCID: https://orcid.org/0000-0002-3032-4087)
- Gustavo Adolfo Ospina-Tascón (ORCID: https://orcid.org/0000-0001-9370-3298)
- Wim J. R. Rietdijk
- Eduardo Kattan
- Daniel De Backer
Institutions
- Université Libre de Bruxelles (BE)
- Pontificia Universidad Católica de Chile (CL)
- Fordham University (US)
- Université Paris-Saclay (FR)
- Erasmus MC (NL)
- Fundación Valle del Lili (CO)
- Maasstad Ziekenhuis (NL)
- Centre Hospitalier Interrégional Edith Cavell (BE)
- Universidad Icesi (CO)
Publication Details
- Journal
- Journal of Critical Care
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1016/j.jcrc.2026.155827
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00